AGF Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
AGF Management's BSX Position: Q2 2026 in Review
AGF Management reduced its Boston Scientific (BSX) stake by 24% in Q2 2026, selling an estimated $1.47M and leaving 85,432 shares worth $3.65M. The position accounts for 0.01% of the portfolio, ranked #300.
AGF Management first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $479M in Q1 2025. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- AGF Management held 85,432 shares of Boston Scientific worth $3.65M as of Q2 2026.
- AGF Management sold 27,051 Boston Scientific shares in Q2 2026, an estimated $1.47M.
- Boston Scientific made up 0.01% of AGF Management's portfolio in Q2 2026, its #300 holding.
- AGF Management first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
- AGF Management's Boston Scientific position peaked at $479M in Q1 2025.
- 1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.